Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monro (MNRO) Cash & Equivalents (2016 - 2025)

Monro's Cash & Equivalents history spans 16 years, with the latest figure at $4.9 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 51.66% year-over-year to $4.9 million; the TTM value through Dec 2025 reached $4.9 million, down 51.66%, while the annual FY2025 figure was $20.8 million, 216.45% up from the prior year.
  • Cash & Equivalents reached $4.9 million in Q4 2025 per MNRO's latest filing, down from $10.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $30.6 million in Q2 2022 to a low of $4.9 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $13.9 million, with a median of $10.3 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: crashed 91.84% in 2021, then skyrocketed 216.45% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $9.5 million in 2021, then soared by 36.63% to $13.0 million in 2022, then surged by 83.44% to $23.8 million in 2023, then tumbled by 57.39% to $10.2 million in 2024, then crashed by 51.66% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for MNRO's Cash & Equivalents are $4.9 million (Q4 2025), $10.5 million (Q3 2025), and $7.8 million (Q2 2025).